The research team from the Queen Mary University of London have identified a peptide, or protein fragment, taken from the foot-and-mouth-disease virus that targets another protein, called AvB6 (alpha-v-beta-6). All this to tackle common cancer with the worst survival rate - pancreatic cancer.